Abiopharma

🔍 BURKE ZANE M (Director)

Company: Owlet, Inc. (OWLT)

Report Date: 2025-10-16

Detailed Transactions and Holdings:

• Acquired 18,996 shares of Common Stock (Direct)
  Date: 2025-10-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 108,002.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 26,785 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 134,787.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: This transaction is being reported late due to an administrative oversight.
• F2: Constitutes restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of the Company's common stock for each RSU upon vesting. The RSUs will fully vest on the earlier of (a) the first anniversary of the date of grant or (b) immediately prior to the next annual meeting of the Company's stockholders after the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.
• REMARKS: Exhibit 24.1 - Power of Attorney